Compare RUN & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUN | ITGR |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.0B |
| IPO Year | 2015 | 2000 |
| Metric | RUN | ITGR |
|---|---|---|
| Price | $11.92 | $85.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 7 |
| Target Price | $20.11 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 10.6M | 968.0K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 113.35 | N/A |
| EPS | 1.71 | ★ 2.89 |
| Revenue | $858,578,000.00 | ★ $1,853,637,000.00 |
| Revenue This Year | N/A | $1.69 |
| Revenue Next Year | $12.03 | $6.53 |
| P/E Ratio | ★ $7.14 | $29.90 |
| Revenue Growth | ★ 12.97 | 7.98 |
| 52 Week Low | $5.38 | $62.00 |
| 52 Week High | $22.44 | $127.56 |
| Indicator | RUN | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 29.48 | 47.51 |
| Support Level | $9.56 | $83.08 |
| Resistance Level | $21.35 | $87.54 |
| Average True Range (ATR) | 1.43 | 3.51 |
| MACD | -0.96 | -0.26 |
| Stochastic Oscillator | 4.13 | 12.15 |
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.